CN Stock MarketDetailed Quotes

603193 Runben Biotechnology

Watchlist
  • 17.81
  • +0.52+3.01%
Not Open Aug 8 15:00 CST
7.21BMarket Cap29.98P/E (TTM)

Runben Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Total operating revenue
10.02%166.68M
20.66%1.03B
20.90%823.53M
31.93%579.15M
151.5M
47.06%856.09M
681.16M
438.98M
31.46%582.15M
58.93%442.83M
Operating revenue
10.02%166.68M
20.66%1.03B
20.90%823.53M
31.93%579.15M
--151.5M
47.06%856.09M
--681.16M
--438.98M
31.46%582.15M
58.93%442.83M
Other operating revenue
----
49.30%657.8K
----
121.93%374.76K
----
85.75%440.6K
----
--168.86K
38.51%237.2K
6.71%171.25K
Total operating cost
0.86%130.26M
14.78%772.61M
16.53%611.99M
26.53%439.43M
129.15M
51.14%673.14M
525.18M
347.29M
32.89%445.37M
44.55%335.16M
Operating cost
3.36%73.85M
14.99%450.93M
15.47%361.4M
26.23%257.44M
--71.45M
43.47%392.15M
--312.98M
--203.94M
30.03%273.34M
64.31%210.21M
Operating tax surcharges
59.00%2.49M
7.21%9.52M
14.24%7.72M
49.95%5.21M
--1.57M
30.02%8.88M
--6.75M
--3.47M
53.14%6.83M
33.24%4.46M
Operating expense
14.68%50.25M
15.88%268.74M
18.22%208.67M
28.80%154.66M
--43.82M
72.50%231.91M
--176.51M
--120.07M
41.33%134.44M
24.67%95.12M
Administration expense
2.82%7.19M
30.24%32.95M
9.70%20.29M
6.88%13.88M
--7M
20.74%25.3M
--18.49M
--12.99M
42.70%20.95M
0.17%14.68M
Financial expense
-3,262.73%-10.41M
-230.23%-15.21M
-17.42%-4.34M
-65.26%-3.79M
---309.6K
-21.80%-4.61M
---3.7M
---2.29M
-16,484.15%-3.78M
-101.26%-22.8K
-Interest expense (Financial expense)
-59.71%38.12K
-40.20%256.3K
-34.41%203.02K
-29.58%160.77K
--94.62K
-20.25%428.6K
--309.53K
--228.3K
--537.47K
----
-Interest Income (Financial expense)
-2,341.86%-10.46M
-203.16%-15.56M
-13.19%-4.63M
-56.90%-4.01M
---428.52K
-24.30%-5.13M
---4.09M
---2.55M
-7,095.32%-4.13M
-434.25%-57.4K
Research and development
22.26%6.88M
31.68%25.69M
29.13%18.26M
32.17%12.03M
--5.63M
43.46%19.51M
--14.14M
--9.1M
26.97%13.6M
37.10%10.71M
Credit Impairment Loss
-146.04%-425.58K
-320.14%-148.45K
38.90%-392.31K
31.83%-217.68K
---172.97K
-1,350.82%-35.33K
---642.04K
---319.33K
111.76%2.82K
78.97%-24.02K
Asset Impairment Loss
-746.06%-2.51M
-113.42%-2.41M
63.55%-213.94K
32.43%-403.07K
---296.09K
53.10%-1.13M
---586.97K
---596.49K
-205.79%-2.41M
87.25%-788.46K
Adjustment items of total operating cost
----
----
--0.01
----
----
----
----
----
----
----
Other net revenue
-4,205.82%-1.4M
49.78%4.27M
235.04%4.87M
75.19%1.59M
-32.56K
-30.66%2.85M
1.45M
907.19K
64.59%4.11M
149.17%2.5M
Fair value change income
----
----
----
----
----
----
----
----
----
--361.23K
Invest income
731.16%151.35K
-59.05%838.63K
-58.10%499.65K
-86.09%106.19K
--18.21K
4.58%2.05M
--1.19M
--763.65K
162.27%1.96M
145.22%746.58K
Asset deal income
---210.51K
77.67%84.06K
--83.89K
--84.06K
--0
4,681.75%47.31K
----
----
--989.48
----
Other revenue
279.59%1.59M
207.32%5.91M
228.34%4.89M
90.66%2.02M
--418.29K
-57.84%1.92M
--1.49M
--1.06M
107.02%4.56M
141.90%2.2M
Operating profit
56.91%35.02M
42.42%264.62M
37.46%216.4M
52.60%141.31M
22.32M
31.88%185.8M
157.43M
92.6M
27.88%140.89M
164.21%110.17M
Add:Non operating Income
41,541.59%5.03M
34.20%3.32M
-87.79%292.73K
-97.73%52.19K
--12.07K
146.38%2.47M
--2.4M
--2.3M
1,051.35%1M
17.80%87.2K
Less:Non operating expense
7,740.97%8.23K
1,687.20%10.73K
1,879.70%5.08K
430.07%175.93
--105.02
-99.77%600.4
--256.73
--33.19
1,503.21%259.52K
-48.36%16.19K
Total profit
79.30%40.04M
42.31%267.93M
35.58%216.69M
48.96%141.36M
22.33M
32.93%188.27M
159.83M
94.9M
28.47%141.63M
164.11%110.24M
Less:Income tax cost
277.89%4.57M
48.43%41.9M
26.83%35.96M
33.87%21.89M
--1.21M
34.52%28.23M
--28.35M
--16.35M
35.12%20.98M
155.89%15.53M
Net profit
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
21.12M
32.66%160.04M
131.48M
78.55M
27.38%120.65M
165.51%94.71M
Net profit from continuing operation
67.93%35.47M
41.23%226.03M
37.47%180.73M
----
--21.12M
32.66%160.04M
--131.48M
----
27.38%120.65M
165.51%94.71M
Net profit of parent company owners
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
--21.12M
32.66%160.04M
--131.48M
--78.55M
27.38%120.65M
165.51%94.71M
Earning per share
Basic earning per share
50.00%0.09
36.17%0.64
39.47%0.53
52.17%0.35
--0.06
30.56%0.47
--0.38
--0.23
16.13%0.36
-55.71%0.31
Diluted earning per share
50.00%0.09
36.17%0.64
39.47%0.53
52.17%0.35
--0.06
30.56%0.47
--0.38
--0.23
16.13%0.36
-55.71%0.31
Other composite income
Total composite income
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
21.12M
32.66%160.04M
131.48M
78.55M
27.38%120.65M
165.51%94.71M
Total composite income of parent company owners
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
--21.12M
32.66%160.04M
--131.48M
--78.55M
27.38%120.65M
165.51%94.71M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Unqualified opinion
Unqualified opinion
Auditor
--
Guangdong Sinong Certified Public Accountants Firm (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
Rong Shing Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Total operating revenue 10.02%166.68M20.66%1.03B20.90%823.53M31.93%579.15M151.5M47.06%856.09M681.16M438.98M31.46%582.15M58.93%442.83M
Operating revenue 10.02%166.68M20.66%1.03B20.90%823.53M31.93%579.15M--151.5M47.06%856.09M--681.16M--438.98M31.46%582.15M58.93%442.83M
Other operating revenue ----49.30%657.8K----121.93%374.76K----85.75%440.6K------168.86K38.51%237.2K6.71%171.25K
Total operating cost 0.86%130.26M14.78%772.61M16.53%611.99M26.53%439.43M129.15M51.14%673.14M525.18M347.29M32.89%445.37M44.55%335.16M
Operating cost 3.36%73.85M14.99%450.93M15.47%361.4M26.23%257.44M--71.45M43.47%392.15M--312.98M--203.94M30.03%273.34M64.31%210.21M
Operating tax surcharges 59.00%2.49M7.21%9.52M14.24%7.72M49.95%5.21M--1.57M30.02%8.88M--6.75M--3.47M53.14%6.83M33.24%4.46M
Operating expense 14.68%50.25M15.88%268.74M18.22%208.67M28.80%154.66M--43.82M72.50%231.91M--176.51M--120.07M41.33%134.44M24.67%95.12M
Administration expense 2.82%7.19M30.24%32.95M9.70%20.29M6.88%13.88M--7M20.74%25.3M--18.49M--12.99M42.70%20.95M0.17%14.68M
Financial expense -3,262.73%-10.41M-230.23%-15.21M-17.42%-4.34M-65.26%-3.79M---309.6K-21.80%-4.61M---3.7M---2.29M-16,484.15%-3.78M-101.26%-22.8K
-Interest expense (Financial expense) -59.71%38.12K-40.20%256.3K-34.41%203.02K-29.58%160.77K--94.62K-20.25%428.6K--309.53K--228.3K--537.47K----
-Interest Income (Financial expense) -2,341.86%-10.46M-203.16%-15.56M-13.19%-4.63M-56.90%-4.01M---428.52K-24.30%-5.13M---4.09M---2.55M-7,095.32%-4.13M-434.25%-57.4K
Research and development 22.26%6.88M31.68%25.69M29.13%18.26M32.17%12.03M--5.63M43.46%19.51M--14.14M--9.1M26.97%13.6M37.10%10.71M
Credit Impairment Loss -146.04%-425.58K-320.14%-148.45K38.90%-392.31K31.83%-217.68K---172.97K-1,350.82%-35.33K---642.04K---319.33K111.76%2.82K78.97%-24.02K
Asset Impairment Loss -746.06%-2.51M-113.42%-2.41M63.55%-213.94K32.43%-403.07K---296.09K53.10%-1.13M---586.97K---596.49K-205.79%-2.41M87.25%-788.46K
Adjustment items of total operating cost ----------0.01----------------------------
Other net revenue -4,205.82%-1.4M49.78%4.27M235.04%4.87M75.19%1.59M-32.56K-30.66%2.85M1.45M907.19K64.59%4.11M149.17%2.5M
Fair value change income --------------------------------------361.23K
Invest income 731.16%151.35K-59.05%838.63K-58.10%499.65K-86.09%106.19K--18.21K4.58%2.05M--1.19M--763.65K162.27%1.96M145.22%746.58K
Asset deal income ---210.51K77.67%84.06K--83.89K--84.06K--04,681.75%47.31K----------989.48----
Other revenue 279.59%1.59M207.32%5.91M228.34%4.89M90.66%2.02M--418.29K-57.84%1.92M--1.49M--1.06M107.02%4.56M141.90%2.2M
Operating profit 56.91%35.02M42.42%264.62M37.46%216.4M52.60%141.31M22.32M31.88%185.8M157.43M92.6M27.88%140.89M164.21%110.17M
Add:Non operating Income 41,541.59%5.03M34.20%3.32M-87.79%292.73K-97.73%52.19K--12.07K146.38%2.47M--2.4M--2.3M1,051.35%1M17.80%87.2K
Less:Non operating expense 7,740.97%8.23K1,687.20%10.73K1,879.70%5.08K430.07%175.93--105.02-99.77%600.4--256.73--33.191,503.21%259.52K-48.36%16.19K
Total profit 79.30%40.04M42.31%267.93M35.58%216.69M48.96%141.36M22.33M32.93%188.27M159.83M94.9M28.47%141.63M164.11%110.24M
Less:Income tax cost 277.89%4.57M48.43%41.9M26.83%35.96M33.87%21.89M--1.21M34.52%28.23M--28.35M--16.35M35.12%20.98M155.89%15.53M
Net profit 67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M21.12M32.66%160.04M131.48M78.55M27.38%120.65M165.51%94.71M
Net profit from continuing operation 67.93%35.47M41.23%226.03M37.47%180.73M------21.12M32.66%160.04M--131.48M----27.38%120.65M165.51%94.71M
Net profit of parent company owners 67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M--21.12M32.66%160.04M--131.48M--78.55M27.38%120.65M165.51%94.71M
Earning per share
Basic earning per share 50.00%0.0936.17%0.6439.47%0.5352.17%0.35--0.0630.56%0.47--0.38--0.2316.13%0.36-55.71%0.31
Diluted earning per share 50.00%0.0936.17%0.6439.47%0.5352.17%0.35--0.0630.56%0.47--0.38--0.2316.13%0.36-55.71%0.31
Other composite income
Total composite income 67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M21.12M32.66%160.04M131.48M78.55M27.38%120.65M165.51%94.71M
Total composite income of parent company owners 67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M--21.12M32.66%160.04M--131.48M--78.55M27.38%120.65M165.51%94.71M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion----Unqualified opinionUnqualified opinion
Auditor --Guangdong Sinong Certified Public Accountants Firm (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)----Rong Shing Certified Public Accountants (Special General Partnership)Rong Shing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg